| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000177337.3 |
Tanespimycin |
Breast invasive carcinoma |
0.025140885 |
Resistant |
| ENSG00000177337.3 |
Tanespimycin |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035538794 |
Resistant |
| ENSG00000177337.3 |
Tanespimycin |
Lung squamous cell carcinoma |
0.027585129 |
Sensitive |
